Volume 1, Issue 1 (Avicenna Journal of Pharmaceutical Research, Jun 2020)                   Avicenna J Pharma Res 2020, 1(1): 37-45 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadi M, Rashidizad S A, Lashkari N, Ataei S, Haddadi R, Mahboobian M M. Supplement Therapy in Multiple Sclerosis: A Pharmacological View. Avicenna J Pharma Res 2020; 1 (1) :37-45
URL: http://ajpr1.umsha.ac.ir/article-1-50-en.html
1- Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
2- Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
3- Department of Pharmaceutics, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
Abstract:   (551 Views)
Natural products, herbal medicines, and supplements have received more attention of the scientific and pharmaceutical community. Supplemental and alternative medicines include dietary supplements, herbs, vitamins, minerals, and special diets. It has been found that some complementary and alternative medicines (CAMs) are safe and effective but the important point is that less is known about many of them. Medicines used in multiple sclerosis (MS) are not completely effective and various side effects have been detected. There is an increasing trend in the use of supplementary and alternative medicines in treating MS because of fewer side effects, more comfort, and more preventative effects. It has been indicated that up to 70%-80% of people with MS have tested herbal products or bioactive compounds for treating their disease. The present study aimed to investigate the use of natural products, herbal remedies, and supplements to treat MS to confirm or rule out the effectiveness or ineffectiveness of these supplementary medicines.
Full-Text [PDF 432 kb]   (47 Downloads)    
Type of Study: case report | Subject: General
Received: 2026/09/28 | Accepted: 2020/08/31 | Published: 2026/09/28

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2026 CC BY-NC 4.0 | Avicenna Journal of Pharmaceutical Research

Designed & Developed by : Yektaweb